| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 810.92B | 678.53B | 570.46B | 484.60B | 404.08B |
| Gross Profit | 435.69B | 378.88B | 296.90B | 240.71B | 199.88B |
| EBITDA | 168.44B | 121.35B | 71.33B | 50.30B | 35.88B |
| Net Income | 98.72B | 63.81B | 35.27B | 19.89B | 9.40B |
Balance Sheet | |||||
| Total Assets | 586.48B | 518.99B | 464.12B | 425.07B | 345.77B |
| Cash, Cash Equivalents and Short-Term Investments | 112.27B | 127.02B | 114.00B | 67.38B | 96.30B |
| Total Debt | 98.53B | 117.28B | 132.12B | 139.80B | 110.47B |
| Total Liabilities | 313.12B | 284.05B | 257.31B | 252.33B | 199.23B |
| Stockholders Equity | 271.76B | 233.29B | 205.08B | 170.91B | 146.39B |
Cash Flow | |||||
| Free Cash Flow | 93.49B | 93.40B | 84.84B | -24.87B | 45.84B |
| Operating Cash Flow | 109.91B | 104.83B | 90.14B | -21.43B | 49.15B |
| Investing Cash Flow | -29.41B | -7.77B | -4.84B | -14.48B | -10.17B |
| Financing Cash Flow | -105.88B | -84.32B | -40.10B | 2.31B | -25.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥697.91B | 14.02 | 12.11% | 2.68% | 2.99% | 5.66% | |
74 Outperform | ¥275.88B | 11.87 | 10.61% | 1.81% | 5.29% | 16.34% | |
73 Outperform | ¥3.13T | 27.18 | 34.14% | 0.56% | 20.12% | 43.82% | |
70 Outperform | ¥548.67B | 12.60 | 4.89% | 2.59% | -0.26% | 129.15% | |
63 Neutral | ¥1.43T | 42.60 | 5.92% | 1.93% | 7.64% | 22.13% | |
62 Neutral | ¥266.08B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |